CVR 30723732Public limited company (A/S)Engroshandel med medicinalvarer og sygeplejeartikler (464610)København VFounded 10 Jul 2007
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about BASILEA PHARMACEUTICALS A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
0
CVR registry, 2012
Gross profit
-35.5K
DKK, annual report 2016
Result
+16K
DKK, annual report 2016
Equity
4.2M
DKK, annual report 2016
Basilea Pharmaceutica AG100% of capital and votes, until 19 Sep 2017
Arne Wiechmannuntil 19 Sep 2017
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
100% of capital and votes16 Apr 2009 to 19 Sep 2017
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
10 Jul 2007 to 31 Oct 2026.
| Metric | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Gross profit | 3,865 | Not reported | Not reported | Not reported | -36 |
| Operating profit | +1,220 | -328 | -68 | -60 | -36 |
| Result for the year | +920 | -274 | -14 | -31 | +16 |
| Equity | 4,503 | 4,229 | 4,215 | 4,184 | 4,200 |
| Total assets | 4,678 | 4,578 | 4,533 | 4,502 | 4,215 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | -31% | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | n.m.note 2 |
| EBITDA | 1,233 | -328 | Not reportednote 3 | Not reportednote 3 | Not reportednote 3 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | 31.9% | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | n.m.note 4 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -1,065note 5 | -1,533note 5 | -1,468note 5 | -1,517note 5 | -509note 5 |
| Gearing, NIBD / EBITDA | Net cashnote 5 | n.m.note 6 | Not reportednote 3 | Not reportednote 3 | Not reportednote 3 |
| ROIC (afkast af investeret kapital) | 37%note 5 | -8.3%note 7 | -1.9%note 7 | -1.7%note 7 | -1.1%note 5 |
| Capex (investeringer i anlægsaktiver) | 0note 8 | Not reportednote 9 | Not reportednote 9 | Not reportednote 9 | Not reportednote 9 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -4,017note 5 | -4,274note 5 | -4,176note 5 | -4,199note 5 | -4,213note 5 |
DKK thousands. Annual reports via XBRL.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2016
1 Jan 2016 to 31 Dec 2016, published 31 May 2017
Annual report 2015
1 Jan 2015 to 31 Dec 2015, published 20 May 2016
Annual report 2014
1 Jan 2014 to 31 Dec 2014, published 7 May 2015
Annual report 2013
1 Jan 2013 to 31 Dec 2013, published 3 Jun 2014
Annual report 2012
1 Jan 2012 to 31 Dec 2012, published 5 Jun 2013
1 registered in CVR.
P-number 1013472625Havneholmen 29, 1561 København V
